Lowe`s Companies Inc vs Oscar Health Inc — how do they compare? Lowe`s Companies Inc trades at $186 (market cap $105.96B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Lowe`s Companies Inc is far larger — about 10.4× Oscar Health Inc's market cap, and Lowe`s Companies Inc pays a 2.65% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lowe`s Companies Inc for 98 Days and Oscar Health Inc for 15 Days on average.
| LOW | OSCR | |
|---|---|---|
Market Cap | $105.96B | $10.22B |
Volume | 4,039,547 | 4,123,394 |
Sector | Consumer Cyclical | Health |
52-Week High | $287.39 | $33.81 |
52-Week Low | $179.50 | $10.85 |
Typical Hold Time | 98 Days | 15 Days |
Enterprise Value | $144.81B | $6.57B |
Dividend Yield | 2.65% | — |
Signals from Pluang's Aura AI — not financial advice
Lowe's (LOW) trades at $186.00, up 2.46% with recent earnings beats but faces bearish technical signals. The stock shows solid fundamentals with a P/E of 15.96 and net margin of 7.35%, though revenue has declined from $96.2B in 2022 to $83.7B in 2025. Recent news highlights drone delivery innovation with DoorDash and Alphabet, while the home improvement sector faces macroeconomic headwinds.
Wall Street maintains a bullish consensus with a $244.09 price target (31 Buy, 19 Hold, 1 Sell), representing 31% upside potential. Key risks include housing market stagnation and competitive pressure from Home Depot. The negative shareholder equity position requires monitoring, but consistent dividend payments and operational cash flow strength provide stability.
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →